Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Featured News
September 2, 2016
Featured News
August 31, 2016
Research
August 30, 2016
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community